Prof. Tufan TÜKEK

Publication Network

Articles 136

1. Association of Apolipoprotein C-III Gene Polymorphisms (rs2854116 and rs2854117) with Susceptibility to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Turkish Population

KARAAĞAÇ D., MORKUZU S., ŞENKAL N., BİLGİN E., Oyaci Y., TÜKEK T., et al.

MEDICINA-LITHUANIA , vol.61, no.8, 2025 (SCI-Expanded)

2. The Association Between Depression and Antidiabetic Treatments in Type 2 Diabetes Patients with Both Good and Poor Glycemic Control

Gumuskaya P. O., Altun O., Yildirim E., Yuztas N. K., Ozsoy N., Kalyon S., et al.

Journal of Clinical Medicine , vol.14, no.10, 2025 (SCI-Expanded) Sustainable Development

3. Evaluation of Acute Enteritis Cases in Adults Presenting to the Emergency Department: A Single Tertiary Care Hospital Experience

DIRIM M. G., Senkal N., Konyaoğlu H., akın k., Emekdaş B., Medetalibeyoglu A., et al.

Sakarya Tıp Dergisi , vol.15, no.1, pp.16-22, 2025 (Peer-Reviewed Journal)

4. Additional Benefits of Serum Oncostatin M Levels Compared to Cardiac Troponin in Non-ST Elevation Myocardial Infarction

Akarsu M., Atici A., Yoldemir Ş., Özcan M., Yildirim Ö., Akarsu H., et al.

Acta Cardiologica Sinica , vol.40, no.3, pp.281-291, 2024 (SCI-Expanded)

5. NT-proCNP levels predict higher atherosclerotic cardiovascular risk profile in patients with proliferative diabetic retinopathy

Karaca C., Bektas M., DİNÇER M. Z., Bakkaloglu O. K., Cebeci Z., BAKIR KAYI A., et al.

Acta Diabetologica , vol.60, no.8, pp.1027-1036, 2023 (SCI-Expanded) Sustainable Development

6. The suppressor of cytokine signaling-1 (SOCS1) gene polymorphism and promoter methylation correlate with the course of COVID-19.

Tukek T., PEHLİVAN S., Medetalibeyoglu A., Serin I., Oyacı Y., Arıcı H., et al.

Pathogens and global health , vol.117, no.4, pp.392-400, 2023 (SCI-Expanded, Scopus) Sustainable Development

7. Impact of Health Workers' Choice of COVID-19 Vaccine Booster on Immunization Levels in Istanbul, Turkey

ÖREN M. M., CANBAZ S., MEŞE S., AĞAÇFİDAN A., DEMİR Ö. S., KARACA ÜNYILDIZ E., et al.

VACCINES , vol.11, no.5, 2023 (SCI-Expanded)

8. Evaluation of depression, anxiety, and stress symptoms and their relationship with subclinical myocardial dysfunction by left ventricular global longitudinal strain in patients who recovered from COVID-19

Baykız D., Polat I., Govdeli E. A., Karaca Özer P., Karaayvaz E. B., Köroğlu S. B., et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES , vol.365, no.2, pp.130-144, 2023 (SCI-Expanded, Scopus)

9. ASSESSMENT OF THE RANSON SCORE IN ACUTE PANCREATITIS: ITS VALUE IN AN EMERGENCY SETTING UPON ADMISSION AKUT PANKREATİTTE RANSON SKORUNUN DEĞERLENDİRİLMESİ: ACİL SERVİSE BAŞVURU ANINDA DEĞERİ

Şenkal N., Karahan L., Bardak A. E., Konyaoğlu H., Teberi̇K Kama E., İNci İ., et al.

Istanbul Tip Fakultesi Dergisi , vol.86, no.3, pp.198-203, 2023 (ESCI, Scopus, TRDizin)

10. The effect of DNA repair gene variants on COVID-19 disease: susceptibility, severity, and clinical course

Senkal N., Serin I., PEHLİVAN S., Pehlivan M., Medetalibeyoglu A., Cebeci T., et al.

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS , vol.42, no.8, pp.571-585, 2023 (SCI-Expanded, Scopus) Sustainable Development

11. Independent risk factors for COVID-19-associated coagulopathy

Tor Y., Ozbalak M. M., Kalayoglu-Besisik S., Aksoy E., Cagatay A., Gul A., et al.

European Review for Medical and Pharmacological Sciences , vol.27, no.16, pp.7851-7860, 2023 (SCI-Expanded, Scopus) Sustainable Development

12. Comparison of clinical characteristics and outcome measures of PCR-positive and PCR-negative patients diagnosed as COVID-19: Analyses focusing on the older adults

Senkal N., Bahat G., Medetalibeyoglu A., Cebeci T., Deniz D., Catma Y., et al.

EXPERIMENTAL GERONTOLOGY , vol.170, 2022 (SCI-Expanded, Scopus) Sustainable Development

13. Symptomatology and imaging findings in early post-Covid period: A comparative study in older vs younger patients

Bahat G., Medetalibeyoglu A., Senkal N., Cebeci T., Oren M. M., Basaran S., et al.

EXPERIMENTAL GERONTOLOGY , vol.167, 2022 (SCI-Expanded, Scopus) Sustainable Development

14. Mannose-Binding Lectin 2 Gene Polymorphism during Pandemic: COVID-19 Family

Tukek T., Pehlivan S., Oyaci Y., Alkac U. I.

GLOBAL MEDICAL GENETICS , vol.09, no.02, pp.185-188, 2022 (ESCI)

15. Mannose-binding lectin 2 (MBL 2) gene polymorphism during pandemic: COVID-19 family

TÜKEK T., PEHLİVAN S., Oyacı Y., İŞOĞLU Ü.

GLOBAL MEDICAL GENETICS , vol.9, no.2, pp.185-188, 2022 (Peer-Reviewed Journal) Sustainable Development

16. **Investigation of MBL2 and NOS3 functional gene variants in suspected COVID-19 PCR (-) patients.**

Pehlivan S., Köse M., Mese S., Serin I., Senkal N., Oyacı Y., et al.

Pathogens and global health , vol.116, no.3, pp.178-184, 2022 (SCI-Expanded, Scopus)

17. Acute kidney injury in hospitalized COVID-19 patients.

Kanbay M., Medetalibeyoglu A., Kanbay A., Cevik E., Tanriover C., Baygul A., et al.

International urology and nephrology , vol.54, no.5, pp.1097-1104, 2022 (SCI-Expanded, Scopus) Sustainable Development

18. EUTHYROID SICK SYNDROME: PREVALENCE AND PROGNOSIS IN ELDERLY PATIENTS WITH SEPSIS

Cakmak R., Atici A., BEKTAŞ M., AKPINAR T. S., KÖSE M., Yuruyen G., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.85, pp.477-484, 2022 (ESCI)

19. Severe vitamin D deficiency is associated with endothelial inflammation in healthy individuals even in the absence of subclinical atherosclerosis

Kose M., Senkal N., Tukek T., Cebeci T., Atalar S. C., Altinkaynak M., et al.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , no.19, pp.7046-7052, 2022 (SCI-Expanded, Scopus) Sustainable Development

20. Severe vitamin D deficiency is associated with endothelial inflammation in healthy individuals even in the absence of subclinical atherosclerosis

KÖSE M., ŞENKAL N., TÜKEK T., CEBECİ T., ATALAR S. C., ALTINKAYNAK M., et al.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.26, no.19, pp.7046-7052, 2022 (SCI-Expanded) Sustainable Development

21. Can the Serum Endocan Level Be Used as a Biomarker to Predict Subclinical Atherosclerosis in Patients with Prediabetes?

Arman Y., Atici A., Altun O., Sarikaya R., Yoldemir S. A., Akarsu M., et al.

Arquivos brasileiros de cardiologia , vol.119, pp.544-550, 2022 (SCI-Expanded)

22. Diagnostic and prognostic value of Nesfatin-1 in sepsis and septic shock

Toprak I. D., Eruzun H., Kutlu Y., Arman Y., Yumustutan P., Yoldemir S. A., et al.

Journal of Experimental and Clinical Medicine (Turkey) , vol.39, no.1, pp.1-6, 2022 (Scopus)

23. Would Tracking Coagulation Together with Inflamation Markers be a Prospect for COVID-19 Disease Prognosis?

MEDETALİBEYOĞLU A., Kaytaz M., Senkal N., Genc S., Aktar I., ÖMER B., et al.

CLINICAL LABORATORY , vol.68, pp.1159-1166, 2022 (SCI-Expanded, Scopus) Sustainable Development

24. Is There a Link between Circadian Clock Protein PERIOD 3 (PER3) (rs57875989) Variant and the Severity of COVID-19 Infection?

Yesil Sayin G., Pehlivan S., Serin I., Medetalibeyoglu A., Kose M., Agacfidan A., et al.

Current medical science , vol.41, no.6, pp.1075-1080, 2021 (Scopus)

25. Correlation of glycemic regulation and endotrophin in patients with type 2 Diabetes; pilot study

Yoldemir S. A., Arman Y., Akarsu M., Altun O., Ozcan M., Tukek T.

DIABETOLOGY & METABOLIC SYNDROME , vol.13, no.1, 2021 (SCI-Expanded) Sustainable Development

26. Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial

Erelel M., Kaskal M., Akbal-Dagistan Ö., Issever H., Dagistanli A. S., Balkanci H., et al.

PHARMACEUTICS , no.11, 2021 (SCI-Expanded, Scopus)

27. PATIENT CHARACTERISTICS AND RISK FACTORS FOR MORTALITY IN 504 HOSPITALIZED PATIENTS DUE TO COVID-19

Medetalibeyoglu A., Ezirmik E., Senkal N., Bayrakdar S., Aktar I., Akas R., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , 2021 (ESCI)

28. Apelin: A new biomarker in fatty liver disease

Kalyon S., Altun O., Pala A. S., Tukek T.

EUROPEAN JOURNAL OF INFLAMMATION , vol.19, 2021 (SCI-Expanded) Sustainable Development

29. Post-COVID-19 Management: Comprehensive Assessment at Post-COVID-19 Monitoring Centre

BAHAT-ÖZTÜRK G., Günaydın S., MEDETALİBEYOĞLU A., Çatma Y., ŞENKAL N., ÖREN M. M., et al.

European journal of geriatrics and gerontology (Online) , vol.3, no.2, pp.101-107, 2021 (Peer-Reviewed Journal) Sustainable Development

30. Impairment of right ventricular longitudinal strain associated with severity of pneumonia in patients recovered from COVID-19.

Ozer P., Govdeli E. A., Baykiz D., Karaayvaz E. B., Medetalibeyoglu A., Catma Y., et al.

The international journal of cardiovascular imaging , vol.37, pp.2387-2397, 2021 (SCI-Expanded, Scopus) Sustainable Development

31. THE RELATIONSHIP BETWEEN sTREM-1 AND ACTIVATION OF INFLAMMATORY BOWEL DISEASES

Kutlu Y., Toprak İ. D., Gokden Y., Eruzun H., Arman Y., Aydin Yoldemir S., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.84, no.3, pp.318-323, 2021 (ESCI)

32. HOW DO WE FOLLOW THE GUIDELINES IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES?

Toprak İ. D., Alibakan O. K., Kostek B., Acar M. A., Aslan I. B., Yilmaz U., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.84, no.3, pp.369-375, 2021 (ESCI) Sustainable Development

33. The association of laminin levels with insulin resistance and non-alcoholic hepatosteatosis

Altun O., Arman Y., Yoldemir S. A., Pala A. S., Gumuskaya P. O., Ozcan M., et al.

DIABETOLOGY & METABOLIC SYNDROME , vol.13, no.1, 2021 (SCI-Expanded)

34. Wide QRS Complex and Lateral ST-T Segment Abnormality Are Associated With Worse Clinical Outcomes in COVID-19 Patients

Sonsoz M. R., Oncul A., Cevik E., Orta H., Yilmaz M., Ayduk Govdeli E., et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES , no.5, pp.591-597, 2021 (SCI-Expanded, Scopus) Sustainable Development

35. Effects of adjunct treatment with intravenous immunoglobulins on the course of severe COVID-19: results from a retrospective cohort study

Esen F., Özcan P. E., Orhun G., Polat Ö., Anaklı İ., Alay G., et al.

CURRENT MEDICAL RESEARCH AND OPINION , vol.37, no.4, pp.543-548, 2021 (SCI-Expanded, Scopus) Sustainable Development

36. Mannose binding lectin gene 2 (rs1800450) missense variant may contribute to development and severity of COVID-19 infection.

Medetalibeyoglu A., Bahat G., Senkal N., Kose M., Avcı K., Sayın G., et al.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases , vol.89, pp.104717, 2021 (SCI-Expanded, Scopus) Sustainable Development

37. Use of Insulin Degludec/Insulin Aspart in the Management of Diabetes Mellitus: Expert Panel Recommendations on Appropriate Practice Patterns

Demir T., DEMİRCİOĞLU S., ÜNLÜHİZARCI K., Topaloglu O., Tukek T., YAVUZ D.

FRONTIERS IN ENDOCRINOLOGY , vol.12, 2021 (SCI-Expanded) Sustainable Development

38. Initial complete blood count score and predicting disease progression in COVID-19 patients.

Ozbalak M. M., Kalayoglu Besisik S., Tor Y. B., Medetalibeyoglu A., Kose M., Senkal N., et al.

American journal of blood research , vol.11, no.1, pp.77-83, 2021 (ESCI) Sustainable Development

39. Serum Endocan Levels on Admission Are Associated With Worse Clinical Outcomes in COVID-19 Patients: A Pilot Study

Medetalibeyoglu A., Emet S., Kose M., Akpinar T. S., Senkal N., Catma Y., et al.

ANGIOLOGY , vol.72, no.2, pp.187-193, 2021 (SCI-Expanded, Scopus) Sustainable Development

40. Multilayer global longitudinal strain assessment of subclinical myocardial dysfunction related to insulin resistance

Atici A., Asoglu R., BARMAN H. A., Sarikaya R., Arman Y., Tukek T.

INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING , vol.37, no.2, pp.539-546, 2021 (SCI-Expanded)

41. Can the endotrophin level in pulmonary fibrosis be a biomarker with differential diagnosis

Ilkhan G. D., Ucsular F. D., Celikhisar H., Arman Y., Yalniz E., Tukek T.

SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , vol.38, no.2, 2021 (SCI-Expanded)

42. Initial complete blood count score and predicting disease progression in COVID-19 patients

Ozbalak M. M., Besisik S., Tor Y. B., Medetalibeyoglu A., Kose M., Senkal N., et al.

AMERICAN JOURNAL OF BLOOD RESEARCH , vol.11, no.1, pp.77-83, 2021 (ESCI) Sustainable Development

43. Older Adults Hospitalized with Covid-19: Clinical Characteristics and Early Outcomes from a Single Center in Istanbul, Turkey

MEDETALİBEYOĞLU A., Senkal N., KÖSE M., ÇATMA Y., Caparali E. B., ERELEL M., et al.

JOURNAL OF NUTRITION HEALTH & AGING , vol.24, no.9, pp.928-937, 2020 (SCI-Expanded, Scopus)

44. Characteristics of the initial patients hospitalized for COVID-19: a single-center report

Medetalibeyoğlu A., Şenkal N., Çapar G., Köse M., Tükek T.

Turkish journal of medical sciences , vol.50, no.5, pp.1436-1439, 2020 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

45. Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19.

Şenkal N., Meral R., Medetalibeyoğlu A., Konyaoğlu H., Kose M., Tukek T.

Anatolian journal of cardiology , vol.24, no.1, pp.21-29, 2020 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

46. Turkish inappropriate medication use in the elderly (TIME) criteria to improve prescribing in older adults: TIME-to-STOP/TIME-to-START

Bahat G., Ilhan B., Erdogan T., Halil M., Savas S., Ulger Z., et al.

EUROPEAN GERIATRIC MEDICINE , vol.11, no.3, pp.491-498, 2020 (SCI-Expanded, Scopus) Sustainable Development

47. The relationship between insulin resistance, obesity, and endotrophin

Aydin Yoldemir S., Arman Y., Akarsu M., Altun O., Dikker O., Toprak İ. D., et al.

INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES , vol.40, no.2, pp.191-195, 2020 (SCI-Expanded) Sustainable Development

48. Relationships among oncostatin M, insulin resistance, and chronic inflammation: a pilot study.

Akarsu M., Hurşitoğlu M., Toprak Z., Yoldemir Ş., Altun Ö., Toprak İ. D., et al.

Archives of endocrinology and metabolism , vol.64, no.1, pp.38-44, 2020 (SCI-Expanded) Sustainable Development

49. DIAGNOSTIC VALUE OF SOLUBLE TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS IN SPONTANEOUS BACTERIAL PERITONITIS

Medetalibeyoglu A., Celik S., Deniz R., Caparali E. B., Kose M., Akpinar T. S., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.83, no.4, pp.390-396, 2020 (ESCI)

50. Reply to the Letter to the Editor "Adropin: Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease".

Kutlu O., Altun Ö., Dikker O., Aktaş Ş., Özsoy N., Arman Y., et al.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre , vol.29, no.1, pp.98, 2020 (SCI-Expanded)

51. The effect of liver test abnormalities on the prognosis of COVID-19.

Medetalibeyoglu A., Catma Y., Senkal N., Ormeci A., Cavus B., Kose M., et al.

Annals of hepatology , vol.19, no.6, pp.614-621, 2020 (SCI-Expanded, Scopus) Sustainable Development

52. Older Adults Hospitalized with Covid-19: Clinical Characteristics and Early Outcomes from a Single Center in Istanbul, Turkey.

Medetalibeyoglu A., Senkal N., Kose M., Catma Y., Bilge Caparali E., Erelel M., et al.

The journal of nutrition, health & aging , vol.24, no.9, pp.928-937, 2020 (SCI-Expanded, Scopus) Sustainable Development

53. Whipple's Disease: A Case Report

Kutlu O., Erhan S. S., Gokden Y., Kandemir O., Tukek T.

MEDICAL PRINCIPLES AND PRACTICE , vol.29, no.1, pp.90-93, 2020 (SCI-Expanded) Sustainable Development

54. The effects of high intensity-interval training on vaspin, adiponectin and leptin levels in women with polycystic ovary syndrome.

Aktaş H., Uzun Y., Kutlu O., Pençe H., Özçelik F., Çil E., et al.

Archives of physiology and biochemistry , pp.1-6, 2019 (SCI-Expanded) Sustainable Development

55. 2019 Turkish Hypertension Consensus Report

Aydogdu S., Guler K., BAYRAM F., ALTUN B., DERİCİ Ü., ABACI A., et al.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.47, no.6, pp.535-546, 2019 (ESCI)

56. The role of kidney injury molecule-1 in predicting cardiorenal syndrome type 1 after diuretic treatment.

ATICI A., Emet S., TOPRAK I., CAKMAK R., AKARSU M., TUKEK T.

Archives of medical sciences. Atherosclerotic diseases , vol.4, 2019 (Peer-Reviewed Journal)

57. Serum endotrophin levels in patients with heart failure with reduced and mid-range ejection fraction.

Eruzun H., Toprak İ. D., Arman Y., Yilmaz U., Ozcan M., Kutlu Y., et al.

European journal of internal medicine , vol.64, pp.29-32, 2019 (SCI-Expanded)

58. Early effect of the fear of terrorism on a hospital's emergency department use and on the incidence of cardiovascular events: A Turkish multicenter study.

Hursitoglu M., Erdal G., Akdeniz E., Kocoglu H., Kocamaz N., Tevetoglu I., et al.

The International journal of health planning and management , vol.34, pp.872-879, 2019 (SSCI) Sustainable Development

59. Serum Adropin Levels Are Reduced in Adult Patients with Nonalcoholic Fatty Liver Disease.

Kutlu O., Altun O., Dikker O., Aktas S., Ozsoy N., Arman Y., et al.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre , vol.28, no.5, pp.463-469, 2019 (SCI-Expanded)

60. Serum Angiopoietin-like peptide 4 levels in patients with hepatic steatosis

Altun O., Dikker O., Arman Y., Ugurlukisi B., Kutlu O., Cil E. O., et al.

CYTOKINE , vol.111, pp.496-499, 2018 (SCI-Expanded)

61. Type I cardiorenal syndrome in patients with acutely decompensated heart failure: the importance of new renal biomarkers.

Atici A., Emet S., Cakmak R., YURUYEN G., Alibeyoglu A., AKARSU M., et al.

European review for medical and pharmacological sciences , vol.22, no.11, pp.3534-3543, 2018 (SCI-Expanded, Scopus)

62. Endocan is markedly overexpressed in severe erectile dysfunction.

Akarsu M., Atalay H., Canat L., Ozcan M., Arman Y., Aydın S., et al.

Andrologia , vol.50, 2018 (SCI-Expanded)

63. Choice of treatment based on Turkish hypertension consensus report: Do we follow the recommendations?

Yuruyen G., Toprak İ. D., Toprak Z., Akarsu M., Demir P., Arman Y., et al.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.46, no.1, pp.25-31, 2018 (ESCI)

64. Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.

Toprak Z., Cebeci E., Helvaci S., Toprak İ. D., Kutlu Y., Sakin A., et al.

International urology and nephrology , vol.49, no.6, pp.1041-1047, 2017 (SCI-Expanded) Sustainable Development

65. The Effects of Blood Glucose Regulation in Omentin-1 Levels among Diabetic Patients

Arman Y., Kirna K., Ugurlukisi B., Kutlu O., Dikker O., Cil E. O., et al.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.125, no.4, pp.262-266, 2017 (SCI-Expanded) Sustainable Development

66. Serum 25-Hydroxy Vitamin D Levels in Patients with Acute Hepatitis (Ischemic, Toxic, and Viral): Association With Clinical Progression and Mortality

Erguven E. A., Arman Y., Arslan K., Kose M., Kutlu O., Akarsu M., et al.

ISTANBUL MEDICAL JOURNAL , vol.18, no.1, pp.23-27, 2017 (ESCI) Sustainable Development

67. COST-EFFECTIVENESS ANALYSIS OF TYPE 2 DIABETES IN OUTPATIENT THERAPY IN TURKEY

Yuruyen G., Ozgun Cil E., Arman Y., Demir P., Cakmak R., Akcan T., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.80, no.3, pp.92-97, 2017 (ESCI) Sustainable Development

68. Turkish doctors' cohort: healthy despite low screening

ÜNAL S., DURUSU TANRIÖVER M., Ascioglu S., DEMİRKAZIK A., Ertenli I., Eskioglu E., et al.

POSTGRADUATE MEDICINE , vol.129, no.3, pp.393-398, 2017 (SCI-Expanded)

69. Microangiopathic Hemolytic Anemia in Metastasized Signet Ring Cell Carcinoma: A Report of Three Cases

YÜCE İNEL T., BAKKALOĞLU O. K., KÖSE M., AKPINAR T. S., TÜKEK T.

International Journal of Hematology Research , vol.2, no.2, pp.136-138, 2016 (Peer-Reviewed Journal) Sustainable Development

70. Effect of Glycemic Regulation on Endocan Levels in Patients With Diabetes: A Preliminary Study.

Arman Y., Akpinar T. S., Kose M., Emet S., Yuruyen G., Akarsu M., et al.

Angiology , vol.67, no.3, pp.239-44, 2016 (SCI-Expanded, Scopus) Sustainable Development

71. Acquired FVIII and FIX Inhibitors after Pregnancy: A Case Report.

Kose M., Bakkaloglu O. K., Amikishiyev S., Akpinar T. S., Saracoglu B., Akcan T., et al.

Acta haematologica , vol.136, no.4, pp.229-232, 2016 (SCI-Expanded)

72. The effect of blood glucose regulation on iron metabolism and hepcidin in uncontrolled type 2 diabetic patients

Arman Y., Ugurlukisi B., Yuruyen G., Akarsu M., Kose M., Cil E. O., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , vol.9, no.2, pp.3869-3876, 2016 (SCI-Expanded) Sustainable Development

73. Acute Coronary Syndrome Process In Geriatric Population: One Year Follow-Up Study

EMET S., AKDOĞAN F., ARMAN Y., KÖSE M., SARAÇOĞLU B., TÜKEK T.

LIFE SCIENCE JOURNAL , 2016 (Peer-Reviewed Journal)

74. Serum endothelial cell specific molecule-1 (endocan) levels in patients with obstructive sleep apnea.

Bingol Z., Kose M., Pihtili A., Akpinar T. S., Tukek T., Kiyan E.

Biomarkers in medicine , vol.10, no.2, pp.177-84, 2016 (SCI-Expanded)

75. DAPSONE-INDUCED METHEMOGLOBINEMIA IN A PATIENT WITH WELLS SYNDROME: A CASE REPORT

Kutlu O., Kocaturk E. O., Cure K., DEMİRKESEN C., Eruzun H., Tukek T.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.79, no.2, pp.96-100, 2016 (ESCI)

76. COMMON VARIABLE IMMUNODEFICIENCY

Kutlu O., Eruzun H., Tukek T.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.79, no.3, pp.122-129, 2016 (ESCI)

77. Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study.

Kose M., Emet S., Akpinar T. S., Kocaaga M., Cakmak R., AKARSU M., et al.

Angiology , vol.66, no.8, pp.727-31, 2015 (SCI-Expanded) Sustainable Development

78. Turkish hypertension consensus report

ARICI M., BİRDANE A., Guler K., Yildiz B. O., ALTUN B., ERTÜRK Ş., et al.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.43, no.4, pp.402-409, 2015 (ESCI) Sustainable Development

79. Evaluation of malnutrition with blood ghrelin and fecal elastase levels in acute decompensated heart failure patients

Ozcan M., Ozturk G. Z., Kose M., Emet S., Aydin S., Arslan K., et al.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.43, no.2, pp.131-137, 2015 (ESCI) Sustainable Development

80. Author's reply.

Emet S., Köse M., Akpınar T. S., Yıldız E., Tükek T.

Anatolian journal of cardiology , vol.15, pp.162-3, 2015 (SCI-Expanded)

81. An unexpected result of obesity treatment: Orlistat-related acute pancreatitis

Köse M., Emet S., Akpınar T. S., İlhan M., Gök A. F. K., Dadashov M., et al.

Case Reports in Gastroenterology , vol.9, pp.152-155, 2015 (Scopus)

82. Relapse of multiple myeloma presenting as extramedullary plasmacytomas in multiple organs.

Kose M., Buraniqi E., Akpinar T. S., Kayacan S. M., Tukek T.

Case reports in hematology , vol.2015, pp.452305, 2015 (ESCI)

83. Relationship between brain natriuretic peptide, microalbuminuria, and contrast-induced nephropathy in patients with acute coronary syndrome.

Yıldız E., Kose M., YURUYEN G., Akpinar T. S., Emet S., ERDEM E., et al.

Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology , vol.14, no.6, pp.505-10, 2014 (SCI-Expanded)

84. Son Kılavuzlar Is ıg ında Korunmus Ejeksiyon Fraksiyonlu Kalp Yetersizlig iIn the Light of Recent Guides Heart Failure Preserved Ejection Fraction

Emet S., ELİTOK A., KÖSE M., TÜKEK T.

İÇ HASTALIKLARI Dergisi , pp.11-16, 2014 (Peer-Reviewed Journal)

85. Son Kılavuzlar Işığında Korunmuş Ejeksiyon Fraksiyonlu Kalp Yetersizliği

EMET S., ELİTOK A., KÖSE M., TÜKEK T.

Türk İç Hastalıkları Uzmanlık Derneği Dergisi , vol.21, pp.11-16, 2014 (Peer-Reviewed Journal)

86. The effect of cystatin-C and pro-BNP in determining mortality in elderly patients with sepsis

Arslan O. A., Ozturk G., Arslan B., TÜKEK T.

EUROPEAN JOURNAL OF THERAPEUTICS , vol.20, no.1, pp.47-51, 2014 (ESCI) Sustainable Development

87. A patient-based study on the adherence of physicians to guidelines for the management of type 2 diabetes in Turkey.

Satman İ., Imamoglu S., Yilmaz C., Akdere T., Akdogan C., Akin H. S., et al.

Diabetes research and clinical practice , vol.98, no.1, pp.75-82, 2012 (SCI-Expanded) Sustainable Development

88. Absolute blood eosinophil count and 1-year mortality risk following hospitalization with acute heart failure.

Cikrikcioglu M., Soysal P., Dikerdem D., Cakirca M., Kazancioglu R., Yolbas S., et al.

European journal of emergency medicine : official journal of the European Society for Emergency Medicine , vol.19, pp.257-63, 2012 (SCI-Expanded)

89. Relationship between HLA molecules and late restenosis after coronary stent placement.

Kudat H., Ozcan M., Tükek T., Sözen A., Akkaya V., Oguz F., et al.

Journal of the Saudi Heart Association , vol.24, pp.85-8, 2012 (SCI-Expanded)

90. Urotensin II levels in patients with chronic kidney disease and kidney transplants.

Hursitoglu M., Tukek T., Cikrikcioglu M., Kara O., Kazancioglu R., Ozkan O., et al.

Upsala journal of medical sciences , vol.117, pp.22-7, 2012 (SCI-Expanded)

91. Rivaroxaban in patients with a recent acute coronary syndrome.

Mega J., Braunwald E., Wiviott S., Bassand J., Bhatt D., Bode C., et al.

The New England journal of medicine , vol.366, pp.9-19, 2012 (SCI-Expanded)

92. Changes in Lipid Profile and Body Mass Index in Patients with Subclinical Hypothyroidism: Evaluation of L-Thyroxine Treatment

Yetmis M., KAZANCIOĞLU R., Erkoc R., TÜKEK T., Peru C., Cikrikcioglu M. A.

HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI , vol.49, no.4, pp.131-135, 2011 (ESCI)

93. Prevalence of gluten sensitive enteropathy antibodies in restless legs syndrome.

Cikrikcioglu M., Halac G., Hursitoglu M., Erkal H., Cakirca M., Kinas B., et al.

Acta neurologica Belgica , vol.111, pp.282-6, 2011 (SCI-Expanded)

94. Oxidative stress and autonomic nervous system functions in restless legs syndrome.

Cikrikcioglu M., Hursitoglu M., Erkal H., Kınas B., Sztajzel J., Cakirca M., et al.

European journal of clinical investigation , vol.41, pp.734-42, 2011 (SCI-Expanded)

95. Rhabdomyolysis secondary to tetanus toxoid administration in a patient following minor laceration.

Hursitoglu M., Cikrikcioglu M., Gundogan E., Ozkan O., Cordan I., Yigit Y., et al.

Journal of clinical pharmacology , vol.51, pp.110-1, 2011 (SCI-Expanded)

96. Idiopathic portal hypertension during a catastrophic attack in a patient with primary antiphospholipid syndrome.

Cikrikcioglu M. A., Erkal H., Hursitoglu M., Karadag A., Gundogan E., Kayacan S. M., et al.

Acta gastro-enterologica Belgica , vol.73, no.4, pp.521-6, 2010 (SCI-Expanded)

97. The interferon-gamma-based QuantiFERON-TB Gold in-tube test and the type of hemodialysis process.

Hursitoglu M., Cakirca M., Cikrikcioglu M., Tukek T.

Swiss medical weekly , vol.140, 2010 (SCI-Expanded)

98. Wilson's disease

Hursitoglu M., Cikrikcioglu M. A., Danalioglu A., TÜKEK T.

CENTRAL EUROPEAN JOURNAL OF MEDICINE , vol.5, no.2, pp.145-149, 2010 (SCI-Expanded)

99. The Prevalence of Low T3 With Arrhythmia and Heart Failure in Patients With Acute Coronary Syndrome

Cikrikcioglu M. A., Elik I., Hursitoglu M., Erkal H., ÇAKIRCA M., Kurt T., et al.

ENDOCRINOLOGIST , vol.20, no.1, pp.23-26, 2010 (SCI-Expanded)

100. Splenomegaly in primary antiphospholipid syndrome without accompanying portal hypertension or comorbidity.

Cikrikcioglu M., Hursitoglu M., Erkal H., Inan B., Ozturk T., Cakirca M., et al.

Pathophysiology of haemostasis and thrombosis , vol.37, pp.104-9, 2010 (SCI-Expanded)

101. Secondary cold agglutinin disease associated with Hashimoto disease

Cikrikcioglu M. A., Hursitoglu M., Erkal H., Karaca N. G., Coraoglu S., TÜKEK T.

CENTRAL EUROPEAN JOURNAL OF MEDICINE , vol.4, no.4, pp.444-449, 2009 (SCI-Expanded)

102. Primary antiphospholipid syndrome presenting as hyponatremic hypertensive syndrome and acute adrenal insufficiency following it: a rare case.

Kurtulmus N., Cikrikcioglu M., Aksoy O., Tukek T.

Rheumatology international , vol.30, pp.259-63, 2009 (SCI-Expanded)

103. Acute effect of low-flux hemodialysis process on the results of the interferon-gamma-based QuantiFERON-TB Gold In-Tube test in end-stage renal disease patients.

Hursitoglu M., Cikrikcioglu M., Tukek T., Beycan I., Ahmedova N., Karacuha S., et al.

Transplant infectious disease : an official journal of the Transplantation Society , vol.11, pp.28-32, 2009 (SCI-Expanded)

104. Clinical improvement of a patient with severe Wilson's disease after a single session of therapeutic plasma exchange.

Hursitoglu M., Kara O., Cikrikcioglu M., Celepkulu T., Aydin S., Tukek T.

Journal of clinical apheresis , vol.24, pp.25-7, 2009 (SCI-Expanded)

105. Masked vitamin B12 deficiency anemia as if it was haemolytic anemia.

Cikrikcioglu M., Benli A., Erkal H., Korkmaz F., Tukek T.

European journal of internal medicine , vol.19, 2008 (SCI-Expanded)

106. THE EFFECTS OF CARVEDILOL ON LEFT VENTRICULAR FUNCTIONS AND ARRHYTHMIAS IN PATIENTS WITH SEVERE CARDIAC FAILURE

TÜKEK T., Canbaz B., Cikrikcioglu M., Kurt T., Kurtulmus N., Hursitoglu M.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.71, no.3, pp.84-87, 2008 (ESCI)

107. Differences in risk factors for acute coronary syndromes between men and women

Kurtulmus N., Bos S., Arslan S., Kurt T., Tukek T., Ince N.

ACTA CARDIOLOGICA , vol.62, no.3, pp.251-255, 2007 (SCI-Expanded) Sustainable Development

108. COMPARISON OF THE INFLUENCE OF TWICE DAILY NPH INSULIN VERSUS ONCE DAILY GLARGINE INSULIN ON THE FREQUENCY OF NOCTURNAL HYPOGLYCEMIA IN TYPE 2 DIABETIC PATIENTS WITH CONGESTIVE HEART FAILURE

Kurtulmus N., Demirdogen F., TÜKEK T., Kurt T., Bahtiyar I., ÇAKIRCA M., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.70, no.1, pp.11-15, 2007 (ESCI)

109. Changes in left ventricular outflow and intraventricular flow patterns in hypertension and controls: a Doppler echocardiographic study.

Tukek T., Erdogan D., Tukek S., Akkaya V., Ozcan M.

Acta cardiologica , vol.60, no.3, pp.333-6, 2005 (SCI-Expanded)

110. Effects of amlodipine and fosinopril on heart rate variability and left ventricular mass in mild-to-moderate essential hypertension.

Bilge A., Atilgan D., Tukek T., Ozcan M., Ozben B., Koylan N., et al.

International journal of clinical practice , vol.59, no.3, pp.306-10, 2005 (SCI-Expanded)

111. THE URINARY ALBUMIN EXCRETION RATE IN THE PREDICTION OF EARLY MORTALITY IN PATIENTS WITH ACUTE MYOCADIAL INFARCTION

Bos S., Kurt T., Okuturlar O., TÜKEK T.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.68, no.1, pp.14-18, 2005 (ESCI)

112. Structural, functional and autonomic changes in the cardiovascular system in growth hormone deficient patients.

Erdogan D., Tukek T., Aral F., Oflaz H., Ozaydin M., Kocaman O., et al.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc , vol.9, no.1, pp.19-23, 2004 (SCI-Expanded)

113. Effect of diurnal variability of heart rate on development of arrhythmia in patients with chronic obstructive pulmonary disease

Tukek T., Yildiz P., Atilgan D., Tuzcu V., Eren M., Erk O., et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY , vol.88, no.2-3, pp.199-206, 2003 (SCI-Expanded)

114. Ventricular arrhythmias in patients with COPD are associated with QT dispersion.

Yildiz P., Tukek T., Akkaya V., Sozen A., Yildiz A., Korkut F., et al.

Chest , vol.122, no.6, pp.2055-61, 2002 (SCI-Expanded)

115. Heart rate variability after coronary artery bypass graft surgery: A prospective 3-year follow-up study

Demirel S., Akkaya V., Oflaz H., Tukek T., Erk O.

ANNALS OF NONINVASIVE ELECTROCARDIOLOGY , vol.7, no.3, pp.247-250, 2002 (SCI-Expanded)

116. Factors associated with the development of atrial fibrillation in COPD patients: the role of P-wave dispersion.

Tukek T., Yildiz P., Akkaya V., Karan M., Atilgan D., Yilmaz V., et al.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc , vol.7, no.3, pp.222-7, 2002 (SCI-Expanded)

117. Role of transesophageal echocardiography in diagnosis and management of cardiac hydatid cyst: Report of three cases and review of the literature

ATILGAN D., Kudat H., TUKEK T., OZCAN M., YILDIRIM O., ELMACI T., et al.

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY , vol.15, no.3, pp.271-274, 2002 (SCI-Expanded)

118. Increased QT dispersion in hemodialysis patients improve after renal transplantation: a prospective-controlled study.

Yildiz A., Akkaya V., Tukek T., Sahin S., Sever M., Bozfakioglu S., et al.

Transplantation , vol.72, no.9, pp.1523-6, 2001 (SCI-Expanded)

119. Effect of left atrial size and function on P-wave dispersion: a study in patients with paroxysmal atrial fibrillation.

Tukek T., Akkaya V., Atilgan D., Demirel S., Ozcan M., Guven O., et al.

Clinical cardiology , vol.24, no.10, pp.676-80, 2001 (SCI-Expanded)

120. Relationship between HLA-C locus and restenosis after coronary artery stenting

TUKEK T., OZCAN M., SOZEN A. B., AKKAYA V. A., Kudat H., DEMIREL S., et al.

EUROPEAN HEART JOURNAL , vol.22, pp.279, 2001 (SCI-Expanded)

121. Assessment of left atrial appendage function and its relationship to pulmonary venous flow pattern by transesophageal echocardiography

TUKEK T., ATILGAN D., AKKAYA V. A., Kudat H., DEMIREL S., OZCAN M., et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY , vol.78, no.2, pp.121-126, 2001 (SCI-Expanded)

122. Risk factors for coronary heart disease in patients with spinal cord injury in Turkey

Demirel S., Demirel G., Tukek T., Erk O., Yilmaz H.

SPINAL CORD , vol.39, no.3, pp.134-138, 2001 (SCI-Expanded)

123. QT dispersion and signal-averaged electrocardiogram in hemodialysis and CAPD patients.

Yildiz A., Akkaya V., Sahin S., Tukek T., Besler M., Bozfakioglu S., et al.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis , vol.21, no.2, pp.186-92, 2001 (SCI-Expanded)

124. The effect of fluvastatin of hyperlipidemia in renal transplant recipients: a prospective, placebo-controlled study.

Türk S., Yildiz A., Tükek T., Akkaya V., Aras U., Türkmen A., et al.

International urology and nephrology , vol.32, pp.713-6, 2001 (SCI-Expanded)

125. Atriyal fibrilasyon saptanan hipertansif hastalarda sol atriyum boyut ve fonksiyonları ile P dalga dispersiyonu değişimleri

Tükek T., Akkaya V. A., Demirel A. Ş., Sözen A. B., Kudat H.

, vol.28, no.9, pp.538-542, 2000 (Peer-Reviewed Journal)

126. Transesophageal echocardiography in the treatment of right atrial hydatid cyst. Its impact on diagnosis and surgical management.

Tukek T., Demirel S., Atilgan D., Akkaya V., Onursal E.

The Journal of cardiovascular surgery , vol.41, no.4, pp.651-2, 2000 (SCI-Expanded)

127. Assessment of left atrial appendage function and its influence on pulmonary venous flow pattern by transoesophageal echocardiography

ATYLGAN D., AKKAYA V. A., Kudat H., TUKEK T., OZCAN M.

EUROPEAN HEART JOURNAL , vol.21, pp.579, 2000 (SCI-Expanded)

128. Echocardiographic findings in professional league soccer players - Effect of the position of the players on the echocardiographic parameters

SOZEN A. B., AKKAYA V. A., DEMIREL S., Kudat H., TUKEK T., UNAL M., et al.

JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS , vol.40, no.2, pp.150-155, 2000 (SCI-Expanded)

129. Effect of Valsalva maneuver on surface electrocardiographic P-wave dispersion in paroxysmal atrial fibrillation

TUKEK T., AKKAYA V. A., DEMIREL S., SOZEN A. B., Kudat H., ATILGAN D., et al.

AMERICAN JOURNAL OF CARDIOLOGY , vol.85, no.7, pp.896-900, 2000 (SCI-Expanded)

130. No association between deletion-type angiotensin-converting enzyme gene polymorphism and left-ventricular hypertrophy in hemodialysis patients.

Yildiz A., Akkaya V., Hatemi A., Cine N., Tukek T., Gorcin B., et al.

Nephron , vol.84, no.2, pp.130-5, 2000 (SCI-Expanded)

131. Effect of Valsalva Maneuver on QT Dispersion in Hemodialysis Patients.

Akkaya V., Y L., Tükek T., Aysuna N., At L., Bozfak O., et al.

Hemodialysis international. International Symposium on Home Hemodialysis , vol.4, pp.18-21, 2000 (SCI-Expanded)

132. Heart rate variability after coronary artery bypass grafting.

Demirel S., Tükek T., Akkaya V., Atilgan D., Ozcan M., Güven O.

The American journal of cardiology , vol.84, pp.496-7, 1999 (SCI-Expanded)

133. Kronik olarak tam tıkalı koroner artere uygulanan perkütan transluminal anjiyoplasti sonuçlarının değerlendirilmesi

Tükek T., Nişancı Y., YILMAZ E., UMMAN B., ÖNCÜL A., MERCANOĞLU F., et al.

İSTANBUL ÜNİVERSİTESİ İSTANBUL TIP FAKÜLTESİ MECMUASI , no.62, pp.56-60, 1999 (Peer-Reviewed Journal)

134. Autonomic dysfunction in vitamin B12 deficiency: A heart rate variability study

Sozen A., Demirel S., Akkaya V., Kudat H., Tukek T., Yeneral M. N., et al.

JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM , vol.71, no.1, pp.25-27, 1998 (SCI-Expanded)

135. An open-label, uncontrolled trial of the angiotensin-converting enzyme inhibitor cilazapril in the treatment of patients with chronic congestive heart failure

Demirel Ş., Akkaya V., Dinç C., Sozen A. B., Metin G., Kudat H., et al.

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL , vol.58, no.9, pp.594-600, 1997 (SCI-Expanded, Scopus)

136. The evaluation of pulmonary venous (PV) flow in stenosis and atrial fibrillation: Relation with spontaneous echo contrast and thrombus Puloner ven akimlarinin mitral stenoz ve atrial fibrillasyon vakalarinda incelenmesi: Spontan kontrast ve trombus ile iliskisi

AKKAYA V. A., Demirel S., Atilgan D., KUDAT H., SÖZEN A. B., ÖZCAN M., et al.

Istanbul Tip Fakultesi Mecmuasi , vol.60, no.1, pp.76-79, 1997 (Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences 57

1. Analysis genomic profiles of type 2 diabetes patients with COVID-19 by next-generation sequencing method in Turkish population

Cacına C., Çakiris A., Abacı N., Sırma Ekmekci S., Bayrak A. E., Medetalibeyoğlu A., et al.

49th FEBS Congress, İstanbul, Turkey, 5 - 09 July 2025, vol.15, no.2, pp.112, (Summary Text)

2. TIP 2 DIYABETES MELLITUS, KRONIK BÖBREK YETERSIZLIĞI VE KALP YETERSIZLIĞI TANISI OLAN HASTALARDA SGLT-2 İNHIBITÖRÜ TEDAVISI KULLANIMININ RETROSPEKTIF DEĞERLENDIRILMESI

Deniz D., Erkul B., Karakaya N. R., Can B., Kahvecioğlu E. D., Altınkaynak M., et al.

26. ULUSAL İÇ HASTALIKLARI KONGRESİ , Girne, Cyprus (Kktc), 2 - 06 October 2024, pp.162-163, (Summary Text)

3. GERIATRIK POPÜLASYONDA DEMIR +2 VE DEMIR +3 PREPARATLARININ ETKINLIĞI VE HASTA UYUMUNUN KARŞILAŞTIRILMASI

Deniz D., Küçük C., Emekdaş B., Şenkal N., Tükek T.

26. ULUSAL İÇ HASTALIKLARI KONGRESİ , Girne, Cyprus (Kktc), 2 - 06 October 2024, pp.135, (Summary Text)

4. Is there a relationship between global 5-methylcytosine and 5-hydroxymethylcytosine levels and metabolic syndrome and its clinical findings?

Pehlivan S., Şenkal N., Oyacı Y., Teberik Kama E., Pehlivan M., Tükek T., et al.

European Human Genetics Conference, Berlin, Germany, 1 - 04 June 2024, pp.100-101, (Summary Text)

5. Analysis of lncrna expression in patients with metabolic syndrome: an investigation based on RNA- sequencing data

Oyacı Y., Şenkal N., Medetalibeyoğlu A., Tuncel F. C., Köse M., Tükek T., et al.

European Human Genetics Conference, Berlin, Germany, 1 - 04 June 2024, pp.100-101, (Summary Text)

6. Metabolik Sendrom Hastalarında Adiponektin Gen Varyantlarının (rs17300539, rs266729 ve rs2241766) Araştırılması: Ön Çalışma

Pehlivan S., Şenkal N., Oyacı Y., Köse M., Medetalibeyoğlu A., Tükek T.

25. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 8 - 12 November 2023, pp.26-27, (Summary Text)

7. Koroner Arter Hastalığı ve Diyabet Birlikteliğinde Obezite Paradoksu

YAVUZ M. L., AYDOĞAN M., ŞENKAL N., KARACA ÖZER P., EMET S., KÖSE M., et al.

25.Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 8 - 12 November 2023, (Full Text) Sustainable Development

8. KORONER ARTER HASTALIĞI VE DİYABET BİRLİKTELİĞİNDE OBEZİTE PARADOKSU

Yavuz M. L., Aydoğan M., Şenkal N., Karaca Özer P., Emet S., Köse M., et al.

25. ULUSAL İÇ HASTALIKLARI KONGRESİ, Antalya, Turkey, 8 - 12 November 2023, pp.83, (Full Text) Sustainable Development

9. Demir eksikliği ve D vitamini eksikliği ile başvuran hastaların demir ve D vitamini preparatlarına uyumu

Konyaoğlu H., Şenkal N., Tükek T.

3. Geleneksel Demir Kampı, İzmir, Turkey, 13 - 15 October 2023, pp.11, (Summary Text)

10. Could Telomere Length Be a Biomarker in Metabolic Syndrome?

Şenkal N., Tuncel F. C., Tükek T., Oyacı Y., Pehlivan M., Pehlivan S.

2nd Internatıonal Cankaya Congress, Ankara, Turkey, 28 - 29 September 2023, pp.20-22, (Full Text)

11. COVID-19 İMMÜNOLOJİSİ İÇİN YENİ FİKİRLER: SİTOKİN SİNYALLEME BASKILAYICISI-1 (SOCS-1) GENİ rs33989964 POLİMORFİZMİ, GLOBAL DNA VE SOCS-1 GEN PROMOTÖRÜ METİLASYONU

Tükek T., Pehlivan S., Medetalibeyoğlu A., Serin İ., Oyacı Y., Arıcı H., et al.

7. ULUSLARARASI ERCİYES BİLİMSEL ARAŞTIRMALAR KONGRESİ, Kayseri, Turkey, 9 - 10 March 2022, pp.159-168, (Full Text)

12. Covid-19 Tanısı Konulan Hastalarda İnterlökin-17'nin Patojenik Varyantının (Rs763780) Laboratuvar Ve Siliko Analizi

Oyacı Y., Şenkal N., Medetalibeyoğlu A., Yeşil Sayın G., Köse M., Pehlivan M., et al.

VIII.International Congress Of Molecular Medicine, İstanbul, Turkey, 9 - 12 November 2021, pp.10, (Full Text) Sustainable Development

13. COVID-19 PCR (-) Hastalarda Mbl2 Ve Nos3 Fonksiyonel Gen Varyantlarının Araştırılması

Pehlivan S., Köse M., Meşe S., Serin I., Şenkal N., Oyacı Y., et al.

Tıbbi Biyoloji ve Genetik Kongresi, İstanbul, Turkey, 28 - 31 October 2021, pp.105, (Summary Text) Sustainable Development

14. Relationship between HLA and COVID-19 in unrelated bone marrow donors

Erol A., D. Öğret Y., Kıvanç D., Süleymanoğlu M., Özbalak M. M., Beşışık B., et al.

Hacettepe Acta Medica- XVII. Congress of Medical Biology and Genetics, 28 - 31 October 2021, vol.52, pp.407-408, (Summary Text)

15. Kemik iliği bağışçılarında HLA ve COVID-19 ilişkisi

EROL A., Öğret Y., KIVANÇ D., SÜLEYMANOĞLU M., ÖZBALAK M. M., Beşışık B., et al.

XVII.Tıbbi Biyoloji ve Genetik Kongresi, 28 October 2021, vol.52, pp.407-408, (Summary Text) Sustainable Development

16. WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?

ERDEM S., MASTANZADE M., ÖZBALAK M. M., KUBİLAY D. Ö., TİRYAKİ T. O., OLUK B., et al.

XIIth Eurasian Hematology-Oncology Congress, İSTANBUL (Hibrit Kongre), Turkey, 10 November 2021, vol.43, pp.96, (Summary Text)

17. PERIOD 3 (PER3) (RS57875989) VARYANTI İLE COVİD-19 ENFEKSİYONUNUN ŞİDDETİ ARASINDA BİR BAĞLANTI OLABİLİR Mİ?

SERİN İ., PEHLİVAN S., KÖSE M., ŞENKAL N., OYACI Y., MEDETALİBEYOĞLU A., et al.

47. Ulusal Hematoloji Kongresi, Turkey, 4 - 07 November 2021, pp.379, (Full Text)

18. DNA ONARIM GEN VARYANTLARI (XRCC4 VE XRCC1) İLE COVİD-19 ENFEKSİYONU ARASINDA BİR BAĞLANTI OLABİLİR Mİ?

SERİN İ., KÖSE M., PEHLİVAN S., ŞENKAL N., PEHLİVAN M., MEDETALİBEYOĞLU A., et al.

47. Ulusal Hematoloji Kongresi, Turkey, 4 - 07 November 2021, pp.358, (Full Text)

19. Dna Onarım Gen Varyantları (Xrcc4 Ve Xrcc1) İle Covıd-19 Enfeksiyonu Arasında Bir Bağlantı Olabilir Mi?

Köse M., Serin I., Pehlivan S., Şenkal N., Pehlivan M., Medetalibeyoğlu A., et al.

Euroasıa Summıt 4th Internatıonal Applıed Scıence Congress, Odessa, Ukraine, 10 - 11 September 2021, vol.1, no.1, pp.125-132, (Full Text)

20. Mannose-Binding Lectin 2 (MBL2) Gene Polymorphism During Pandemic: Covid-19 Family.

Tükek T., Pehlivan S., Oyacı Y., İşoğlu Ü.

4th International Health Sciences And Innovation Congress, Baku, Azerbaijan, 5 - 06 July 2021, vol.1, no.1, pp.704-712, (Full Text)

21. COVID-19 Hastalarında Endotel Nitrik Oksit Sentetaz Geninin (rs1799983 ve Intron 4a/b VNTR) Fonksiyonel Varyantlarının Araştırılması

Şenkal N., Oyacı Y., Köse M., Medetalibeyoğlu A., Önel M., Yeşil Sayın G., et al.

International Symposium On Global Pandemics And Multidisciplinary Covid-19 Studies , Ankara, Turkey, 19 - 20 March 2021, pp.1-7, (Full Text)

22. Investigation of Functional Variants of the Endothelital Nitric Oxide Synthetase Gene (rs1799983 and Intron 4a / b VNTR) in COVID-19 Patients

Şenkal N., Oyacı Y., KÖSE M., MEDETALİBEYOĞLU A., YEŞİL SAYIN G., PEHLİVAN M., et al.

International Symposium On Global Pandemics And Multidisciplinary Covid-19 Studies, 19 - 20 March 2021, pp.1-7, (Full Text) Sustainable Development

23. INVESTIGATION OF FUNCTIONAL VARIANTS OF THE ENDOTHELITAL NITRIC OXIDE SYNTHETASE GENE (rs1799983 AND INTRON 4a/b VNTR-27 BP) IN COVID-19 PATIENTS

ŞENKAL N., OYACI Y., KÖSE M., MEDETALİBEYOĞLU A., ÖNEL M., YEŞİL SAYIN G., et al.

International Symposium on Global Pandemics and Multidisciplinary Covid-19 Studies, Ankara, Turkey, 19 March 2021, (Full Text)

24. COVID-19 SEYRINDE KOAGÜLASYON PARAMETRELERI VE İNFLAMATUAR BELIRTEÇLERDEKI DEĞIŞIMLERIN HASTALIK ŞIDDETIYLE İLIŞKISI

MEDETALİBEYOĞLU A., KAYTAZ A. M., ŞENKAL N., AKIN A., GENÇ N. S., ÖMER B., et al.

Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme, İstanbul, Turkey, 11 March 2021, (Summary Text)

25. Effects of intravenous immunoglobulin (IVIG) on the course of severe COVID‑19: results from a retrospective data analysis of a patient cohort in Turkey treated with or without Octagam®.

Esen F., Ergin Özcan P., Orhun G., Polat Ö., Anaklı İ., Alay G., et al.

33th ESICM Annual Congress, 6 - 09 December 2020, pp.300, (Summary Text)

26. DERIN ANEMI ILE BAŞVURAN GENÇ ERKEK HASTADA GÖRÜLEN MULTIPL MYELOM OLGUSU

Gasımova G., MEDETALİBEYOĞLU A., KÖSE M., AKKAYA V. A., TÜKEK T.

Geleneksel İç Hastalıkları Günleri - İnteraktif Güncelleştirme, Turkey, 11 October 2020, (Summary Text)

27. AORTA-ENTERIK FISTÜLE BAĞLI GELIŞEN GASTROINTESTINAL SISTEM KANAMASI

MEDETALİBEYOĞLU A., BİLGİN E., Gümürdü Ş., TÜKEK T.

2020 Geleneksel İç Hastalıkları Günleri - İnteraktif Güncelleştirme, 11 October 2020, (Summary Text)

28. OBEZITE VE KILO YÖNETIMINDE LIRAGLUTIDIN ETKINLIĞI

MEDETALİBEYOĞLU A., Çetiner S. B. Ç., AKPINAR T. S., KÖSE M., TÜKEK T.

Geleneksel İç Hastalıkları Günleri - İnteraktif Güncelleştirme, Turkey, 12 March 2020, (Summary Text)

29. İyi Klinik Uygulamalar Çerçevesinde Klinik Araştırma Eğitim Değerlendirmesi: İstanbul Tıp Fakültesi Tıbbi ve Klinik Farmakoloji Uygulamaları (INSAC-18-1112)(ISBN: 978-605-69062-0-6)

DEMİR M., DİZDAR M. Y., BEBEK N., AKKAYA V. A., TÜKEK T., GÜRSES R. C., et al.

International Science and Academic Congress'18, Konya, Turkey, 8 - 09 December 2018, vol.1, pp.99-103, (Full Text)

30. EKG KURSU

TÜKEK T., ÖNCÜL A., EMET S.

19. ULUSAL İÇ HASTALIKLARI KONGRESİ, Turkey, 11 - 15 October 2017, (Full Text)

31. SPONTAN BAKTERİYEL PERİTONİT TANISINDA STREM 1 MOLEKÜLÜNÜN ROLÜ

MEDETALİBEYOĞLU A., Deniz R. D., KÖSE M., AKPINAR T. S., ARMAN Y., ATICI A., et al.

Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme, SAPANCA, Turkey, 16 March 2017, (Summary Text)

32. SPONTAN BAKTERİEL PERİTONİT TANISINDA STREM-1 MOLEKÜLÜNÜN ROLÜ

MEDETALİBEYOĞLU A., DENİZ R., KÖSE M., AKPINAR T. S., ARMAN Y., ATICI A., et al.

Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2017, Turkey, 16 - 19 March 2017, (Summary Text)

33. DİYABETİK RETİNOPATİ İLE N TERMİNAL PRO-C TİPİ NATRİÜRETİK PEPTİD DÜZEYİ ARASINDAKİ İLİŞKi

KARACA C., Bakkaloğlu O. K., Yiğit O. O., AKPINAR T. S., CEBECİ Z., ATICI A., et al.

18. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 12 October 2016, (Summary Text)

34. Vakalarla Sistemik Hastalıklarda Kardiyak Tutulum

TÜKEK T., OFLAZ H., KÖSE M., Emet S., ATICI A.

Türk İç Hastalıkları Derneği istanbul avrupa toplantıları, Turkey, 07 April 2016

35. Sistemik Semptomlar ve Labratuar Bulgularıyla Multiple Myleom

YEĞİT O. O., AKAN K., KÖSE M., TÜKEK T.

16. ulusal iç hastalıkları kongresi, Turkey, 15 - 19 October 2015

36. ACI LDE ZOR VAKALAR ZOR KARARLAR

KÖSE M., GÜLER K., YENEREL M. N., TÜKEK T.

17. Ulusal İç Hastalıkları Kongresi, Turkey, 14 - 18 October 2015

37. Hasta ortada kalmasın Multidisipliner yaklaşım

TÜKEK T., TANAKOL R., KAYMAKOĞLU S., YENEREL M. N., KÖSE M.

"Geleneksel İç Hastalıkları Günleri-İnteraktif Güncelleştirme - 2016", Turkey, 11 - 13 March 2015

38. ACİLDE KARDİYAK VAKAYA YAKLAŞIM

TÜKEK T., AKKAYA V. A., KÖSE M., EMET S., ÇAKMAK R.

İSTANBUL TOPLANTILARI 104, Turkey, 08 January 2015

39. Relationship Vitamin D Levels to Early Mortality in Patients with Acute Coronary Syndrome and Value of Vitamin D Levels as a Cardiovascular Risk Factor

EMET S., KOCAAĞA M., ARSLAN K., AKPINAR T. S., KÖSE M., ELİTOK A., et al.

30. Uluslararası Katılımlı Türk Kardiyoloji Kongresi, Antalya, Turkey, 23 - 26 October 2014, (Summary Text)

40. VANKOMİSİN İLİŞKİLİ DRESS SENDROMU

AKAN K., YEĞİT O. O., DEMİR S., KÖSE M., TÜKEK T.

16. ULUSAL İÇ HASTALIKLARI KONGRESİ, Turkey, 15 - 19 October 2014

41. Geriatrik Hastalarda Akut Koroner Sendromun Seyri

AKARSU M., AKDOĞAN F., ÖZCAN M., KÖSE M., AKPINAR T. S., ARMAN Y., et al.

XVI. Ulusal İç Hastalıkları Kongresi Belek Antalya 2014 Sözlü Sunum, Turkey, 15 - 19 October 2014

42. Koroner Arter Hastalığının Şiddetini Belirlemede Endokan Düzeyi Akut Koroner Sendromda Yeni bir Belirteç olabilir mi

EMET S., KÖSE M., AKPINAR T. S., KOCAAĞA M., ARMAN Y., YÜRÜYEN G., et al.

XVI. Ulusal İç Hastalıkları Kongresi Belek Antalya 2014 Sözlü Sunum, Turkey, 15 - 19 October 2014

43. VAKALARLA ACI LDE KANAMALI HASTAYA YAKLAS IM

TÜKEK T., YENEREL M. N., KÖSE M.

16. Ulusal İç Hastalıkları Kongresi, Turkey, 15 - 19 October 2014

44. KORONER ARTER HASTALIĞININ ŞİDDETİNİ BELİRLEMEDE ENDOKAN DÜZEYİ: AKUT KORONER SENDROMDA YENİ BİR BELİRTEÇ OLABİLİR Mİ?

EMET S., KÖSE M., Akpinar T. S., Kocaaga M., Arman Y., Yuruyen G., et al.

16. Ulusal İç hastalıkları Kongresi, Turkey, 15 - 19 October 2014, (Summary Text)

45. İÇ HASTALIKLARINDA ACİL KARDİYOLOJİK SORUNLARA VAKALARLA YAKLAŞIM

TÜKEK T., ÖNCÜL A., DEMİREL A. Ş., KÖSE M., EMET S.

15. Ulusal İç Hastalıkları Kongresi, Turkey, 2 - 06 October 2013

46. AKUT KORONER SENDROM TANISI KONAN HASTALARDA RİSK FAKTÖRÜ OLARAK D VİTAMİN DÜZEYİ VE MORTALİTE İLE İLİŞKİSİ

ARSLAN K., KÖSE M., TOZ B., EMET S., BAKKALOĞLU O. K., ARMAN Y., et al.

15. ULUSAL İÇ HASTALIKLARI KONGRESİ, Turkey, 2 - 06 October 2013

47. MULTİFOKAL LİTİK KEMİK LEZYONLARI İLE SEYREDEN TÜBERKÜLOZ OLGU SUNUMU

KORKMAZ Ü., ALTINKAYNAK M., BAY İ., AKPINAR T. S., KÖSE M., SAKA B., et al.

15. ULUSAL İÇ HASTALIKLARI KONGRESİ, Turkey, 2 - 06 October 2013, (Summary Text) Sustainable Development

48. AKUT KORONER SENDROM TANISI İLE KORONER ANJİOGRAFİ PLANLANAN TİP 2 DİABETES MELLİTUSLU HASTALARDA BNP VE MİKROALBUMİNÜRİ DÜZEYLERİ İLE KONTRAST NEFROPATİ GELİŞİMİ ARASINDAKİ İLİŞKİ

YILDIZ E., ARSLAN K., KÖSE M., EMET S., ARMAN Y., TÜKEK T.

15. ULUSAL İÇ HASTALIKLARI KONGRESİ, Turkey, 2 - 06 October 2013 Sustainable Development

49. İZOLE OKÜLOMOTOR SİNİR FELCİ İLE PREZENTE HIV POZİTİF NÖROSİFİLİZ OLGUSU

AKSOY A., MEMİŞ Z., KÖSE M., AKPINAR T. S., TÜKEK T., KAYACAN S. M., et al.

15. ULUSAL İÇ HASTALIKLARI KONGRESİ, Turkey, 2 - 06 October 2013 Sustainable Development

50. AKUT HEPATİTLİ TOKSİK İSKEMİK VİRAL HASTALARDA SERUM 25 HİDROKSİ VİTAMİN D DÜZEYİ KLİNİK SEYİR VE MORTALİTE İLE İLİŞKİSİ

AYÖZTÜRK VELİOĞLU E., ARSLAN K., KÖSE M., KIRNA K., ARMAN Y., TÜKEK T.

15. ULUSAL İÇ HASTALIKLARI KONGRESİ, Turkey, 2 - 06 October 2013

51. SEPSİSLİ YAŞLI HASTALARDA SİSTATİN C VE PRO BNP NİN MORTALİTE ÜZERİNE ETKİSİ

AKSOY ARSLAN Ö., ÖZTÜRK G. Z., HURŞİTOĞLU M., KARA O., CORDAN İ., YILDIZ İ., et al.

15. ULUSAL İÇ HASTALIKLARI KONGRESİ, Turkey, 2 - 06 October 2013

52. AKUT KORONER SENDROM TANISI İLE KORONER ANJİYOGRAFİ PLANLANAN TİP 2 DİABETES MELLİTUSLU HASTALARDA BNP VE MİKROALBUMİNÜRİ DÜZEYLERİ İLE KONTRAST NEFROPATİ GELİŞİMİ ARASINDAKİ İLİŞKİ

Yildiz E., Arslan K., KÖSE M., EMET S., Arman Y., TÜKEK T.

15. ULUSAL İÇ HASTALIKLARI KONGRESİ, Turkey, 2 - 06 October 2013, (Summary Text)

53. I C HASTALIKLARINDA ACI L KARDI YOLOJI K SORUNLARA VAKALARLA YAKLAS IM

TÜKEK T., ÖNCÜL A., DEMİREL A. Ş., KÖSE M., EMER S.

15. Ulusal İç Hastalıkları Kongresi, Turkey, 2 - 06 June 2013

54. The association of endothelial dysfunction with endothelial constitutive nitric oxide synthase gene polymorphism in different patient populations

DEMIREL S., GENCHALLAC H., OFLAZ H., TUKEK T., Akkaya V. A., CINE N., et al.

19th Meeting of the International-Society-for-Hypertension/12th European-Society-of-Hypertension Meeting, PRAGUE, Czech Republic, 23 - 27 June 2002, vol.20